POZ Pregnasp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-12-06
Share capital
5,000.00 PLN
Registered address
ul. Jeleniogórska 16, 60-179 Poznań, Poland

Financials

Filing timeliness

No financial statement for 2019 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2018, 4 days late).

  • 2019not filed
  • 201819/07/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2018.

Division · Human health activities2,332 / 2,928
Top 80%
Top 80%
Voivodeship · Wielkopolskie39,246 / 49,541
Top 79%
Country · Poland387,209 / 495,867
Top 78%

Results vs industry

Revenue
This companyUSD 20.47kMedianUSD 91.71kAverageUSD 1.38m
Net profit
This companyUSD 12.89kMedianUSD 2.61kAverageUSD 145.69k
Operating costs
This companyUSD 5.31kMedianUSD 82.81kAverageUSD 1.18m
Assets
This companyUSD 17.41kMedianUSD 39.25kAverageUSD 949.40k

Industry

National Health Fund (NFZ) contracts

POZ Pregna has been an NFZ healthcare provider since 2018. In 2019 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2019
Podstawowa Opieka Zdrowotnadolnośląskie1USD 0.00

Authorized Representatives

Michał Wawrzyniak – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Michał Wawrzyniakage 41
50$1,350.62100%

Beneficial owners

Person

Debt

1 closed proceeding recorded in KRZ history.

Registration dateProceeding typeStatus
Nov 27, 2023
Discontinued enforcement proceedings
Closed

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

FAQ

Last updated: 2026-10-07